Legal News

Mylan Investigated for Antitrust Violations
Download PDF
1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Loading...

EpiPen

Summary: After increasing the price of EpiPens so that they are no longer affordable, drugmaker Mylan is being investigated for antitrust violations.

Mylan Pharmaceuticals is being investigated by New York state’s top legal office for the possibility that the drugmaker has broken antitrust laws over the pricing of its EpiPen. New York Attorney General Eric Schneiderman announced that a preliminary analysis had begun into Mylan by his office, including items such as the terms of sales in contracts with local schools.

  
What
Where


Schneiderman said, “No child’s life should be put at risk because a parent, school or health care provider cannot afford a simple, life-saving device because of a drugmaker’s anti-competitive practices. Allergy sufferers have enough concerns to worry about – the availability of life-saving medical treatment should not be one of them.”

Read EpiPen CEO Tied to Democratic Senator.

EpiPen’s are the most popular method of epinephrine autoinjector on the market. The drug is used to treat those having a severe allergic reaction. Mylan increased the price of the EpiPen over 400 percent since 2009. This has raised concern by consumer advocates and critics.

Get JD Journal in Your Mail

Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!!




A generic version was supposed to be made but the FDA has not approved one yet, leaving Mylan’s EpiPen as the only option for consumers that have to pay the price if they want to protect themselves and loved ones. Mylan has stated they will offer a generic version for $300 for the two-pack instead of the $600. They also state they will offer more discounts to make it affordable to users. The EpiPen brings in around $1 billion in profit a year for the pharmaceutical company.

See Big Pharma, Biotech Companies Ask for Patent Protections.



Mylan has given over 700,000 EpiPens for free to more than 65,000 schools across the country. They have also dropped the purchase requirement for schools looking to buy EpiPens at a discount.

Do you think Mylan has done anything wrong by dramatically increasing the price of the life-saving drug? Tell us in the comments below.

To learn more about Mylan, read Retaliation Lawsuit Brought Against Mylan Pharmaceuticals by Ex-Employee.

Photo: the405media.com



 

RELEVANT JOBS

Staff Attorney- Public Benefits

USA-CA-Bakersfield

Greater Bakersfield Legal Assistance, Inc.  (GBLA), a non-profit law firm that provides free ci...

Apply now

Staff Attorney- Community Homeless Law Center

USA-CA-Bakersfield

Greater Bakersfield Legal Assistance, Inc.  (GBLA), a non-profit law firm that provides free ci...

Apply now

Patent Attorney/Agent

USA-FL-Plantation Acres

Full-service intellectual property law firm in a great location near Miami and Fort Lauderdale is ac...

Apply now

Associate Attorney

USA-TX-San Antonio

The Amsberry Law Firm is a boutique law firm focused on representation in the areas of...

Apply now

BCG FEATURED JOB

Locations:

Keyword:



Search Now

Corporate/Transactional Attorney

USA-IA-Des Moines

Des Moines office of a BCG Attorney Search Top Ranked Law Firm seeks corporate/transactional attorne...

Apply Now

Corporate Attorney / Counsel

USA-NY-New York City

New York City office of a BCG Attorney Search Top Ranked Law Firm seeks corporate attorney with 5+ y...

Apply Now

Housing Finance Associate Attorney

USA-MN-Minneapolis

Minneapolis office of a BCG Attorney Search Top Ranked Law Firm seeks a housing finance associate at...

Apply Now

Most Popular

SEARCH IN ARCHIVE

To Top